Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis.

In contrast, the suboptimal dose NalF and NalM treatments (alone or in combination) did not alter IFN‐γ production significantly although the NalM alone effect approached significance (Figure 6b ).

also in 8,237 other papers